Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchison China MediTech Ltd (HCM US)
Watchlist
40
Analysis
Health Care
•
Hong Kong
Hutchison China MediTech Ltd develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchison China MediTech Ltd
•
22 Jan 2020 18:02
Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind
HCM, a leading China biotech company, filed a prospectus to sell USD 110 million of ADS. We have covered the company's fundamentals for its Hong...
Ke Yan, CFA, FRM
Follow
477 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
28 Jun 2019 16:51
Hutchison-China Meditech (和黄医药) Placement: Big Discount After HK Listing Delayed
HCM, a leading China biotech company, filed a prospectus to sell 8.5 million secondary ADSs. We have covered the company's fundamentals for its...
Ke Yan, CFA, FRM
Follow
528 Views
Share
bullish
•
ESR Group
•
08 Jun 2019 12:16
ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
Zhen Zhou, Toh
687 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
25 Apr 2019 15:23
Hutchison-China Meditech (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities
Hutchison-China Meditech, China-based AIM and NASDAQ dual listed pharmaceutical company, is seeking to raise up to USD 500 million via a Hong Kong...
Ke Yan, CFA, FRM
Follow
653 Views
Share
First
Previous
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x